Robert Allen, MD
Dermatopathology · Mount Laurel, NJNPI 1346376845
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $739 of the $824 with a category attached, or 89.7%. It is spread thinly across 16 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations.
Across 50 payments — averaging $16.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$142
- Johnson & Johnson$118
- UCB, Inc.$85
- Novartis$82
- Lilly USA, LLC$71
- E.r. Squibb & Sons, L.L.C.$67
- plus $260 from 10 others
What the payments were for
- Food & beverage$73990%
- Education$8510%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 9 | $142 |
| Johnson & Johnson | 3 | $118 |
| UCB, Inc. | 5 | $85 |
| Novartis | 4 | $82 |
| Lilly USA, LLC | 4 | $71 |
| E.r. Squibb & Sons, L.L.C. | 4 | $67 |
| Arcutis Biotherapeutics, Inc. | 3 | $47 |
| Amgen | 2 | $35 |
| Sanofi | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 2 | $33 |
| Organon | 7 | $26 |
| Sun Pharmaceutical Industries Inc. | 1 | $19 |
| Incyte Corporation | 1 | $18 |
| Genentech USA, Inc. | 1 | $17 |
| Galderma Laboratories, L.p. | 1 | $17 |
| Pfizer | 1 | $15 |
How this compares
Too few dermatopathology providers in New Jerseyto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 131 | $7,851 |
| Tretinoin | 132 | $7,380 |
| Betamethasone Dipropionate | 158 | $6,315 |
| Clobetasol Propionate | 82 | $4,856 |
| Pimecrolimus | 12 | $4,641 |
| Triamcinolone Acetonide | 414 | $3,681 |
| Ketoconazole | 136 | $2,961 |
| Fluocinolone Acetonide | 64 | $2,704 |
| Acitretin | 12 | $2,296 |
| Halobetasol Propionate | 55 | $2,056 |
| Doxycycline Hyclate | 93 | $1,503 |
| Mometasone Furoate | 79 | $1,428 |
| Ammonium Lactate | 101 | $1,385 |
| Imiquimod | 44 | $1,347 |
| Metronidazole | 22 | $1,178 |
Paid to pharmacies, not to this prescriber.
Other dermatopathology in Mount Laurel
- Kelly KaneSomers Point$2K
- Warren HeymannMarlton$1K
- Zheng LiuEnglewood$291
- Kristyna LeeMorristown$259
- Cheryl SmithGlassboro$69
- Pradip BhattacharjeeHolmdel$61
- Amin MaghariToms River$45
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.